Sectors

HTFL
Heartflow, Inc. Common Stock
24.32
2 x 24.32
1 x 24.37
bid
ask
-
1.12
4.40%
11:10 AM
timesize
Ytd-16.57%
1y-15.41%
24.23
day range
25.61
20.13
52 week range
41.22
Open25.18Prev Close25.44Low24.23High25.61Mkt Cap2.19B
Vol136.15KAvg Vol1.48MEPS-2.01P/E-12.66Forward P/E-104.86
BetaN/AShort Ratio3.36Inst. Own79.22%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1350-d Avg29.57200-d Avg29.581yr Est37.00

HTFL News

What Does the HeartFlow CEO's Sale of Over 20,000 Company Shares Mean for Investors?
fool.com
What Does the HeartFlow CEO's Sale of Over 20,000 Company Shares Mean for Investors?

The medical technology company reported a notable insider sale in recent filings.

HeartFlow: A Premium AI Diagnostics Story
seekingalpha.com
HeartFlow: A Premium AI Diagnostics Story

I recommend a buy rating for HeartFlow, Inc. due to its strong clinical workflow integration and exp

New Data at SCCT 2026 Reinforce Heartflow Plaque Analysis as the Standard for AI-Powered Coronary Artery Disease Management
globenewswire.com
New Data at SCCT 2026 Reinforce Heartflow Plaque Analysis as the Standard for AI-Powered Coronary Ar

Heartflow Plaque Staging TM , the only staging tool based on total plaque volume * , is now included

Heartflow vs. Omeros: Which Healthcare Innovator Stock Is a Better Buy in 2026?
fool.com
Heartflow vs. Omeros: Which Healthcare Innovator Stock Is a Better Buy in 2026?

Heartflow uses artificial intelligence to transform coronary imaging into actionable diagnostic data

Heartflow vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?
fool.com
Heartflow vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?

Heartflow leverages AI-enabled software to dominate the non-invasive coronary diagnostic market, bac

benzinga.com
Freedom Capital Markets Initiates Coverage On HeartFlow with Buy Rating, Announces Price Target of $

Freedom Capital Markets analyst Gene Mannheimer initiates coverage on HeartFlow (NASDAQ:HTFL) wit

HeartFlow vs. NovoCure: Which Emerging Healthcare Stock Is a Better Buy in 2026?
fool.com
HeartFlow vs. NovoCure: Which Emerging Healthcare Stock Is a Better Buy in 2026?

AI-powered diagnostics meet global oncology innovation as two medical disruptors post strong revenue

Baron Discovery Fund Q1 2026: Who Moved The Needle
seekingalpha.com
Baron Discovery Fund Q1 2026: Who Moved The Needle

In the first quarter of 2026, Baron Discovery Fund declined 10.65% (Institutional Shares), trailing

Is HeartFlow Stock a Buy After an Institutional Investor Initiated a Position Worth $2.7 Million?
fool.com
Is HeartFlow Stock a Buy After an Institutional Investor Initiated a Position Worth $2.7 Million?

HeartFlow delivers AI-powered, non-invasive cardiac diagnostics for hospitals and cardiology clinics

Heartflow Q1 Earnings Call Highlights
marketbeat.com
Heartflow Q1 Earnings Call Highlights

Heartflow NASDAQ: HTFL reported a sharply higher first-quarter revenue total and raised its full-yea

HeartFlow, Inc. (HTFL) Q1 2026 Earnings Call Transcript
seekingalpha.com
HeartFlow, Inc. (HTFL) Q1 2026 Earnings Call Transcript

HeartFlow, Inc. (HTFL) Q1 2026 Earnings Call Transcript

Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance
globenewswire.com
Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance

SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the lead

Earnings Scheduled For May 14, 2026
benzinga.com
Earnings Scheduled For May 14, 2026

Wall Street Waits for the SpaceX IPO, These 2 Under-the-Radar IPOs Could Already Be Making You Money
fool.com
Wall Street Waits for the SpaceX IPO, These 2 Under-the-Radar IPOs Could Already Be Making You Money

Heartflow and Neptune Insurance deserve a closer look.

Stanford Trustees Exited HeartFlow Stock for $8.5 Million. Here's What That Means for Investors.
fool.com
Stanford Trustees Exited HeartFlow Stock for $8.5 Million. Here's What That Means for Investors.

HeartFlow provides AI-driven tools for non-invasive heart diagnostics, serving hospitals and clinics

Heartflow to Report First Quarter 2026 Financial Results on May 14, 2026
globenewswire.com
Heartflow to Report First Quarter 2026 Financial Results on May 14, 2026

SAN FRANCISCO, April 23, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the le

Heartflow, Inc. (NASDAQ:HTFL) Given Average Rating of “Moderate Buy” by Analysts
defenseworld.net
Heartflow, Inc. (NASDAQ:HTFL) Given Average Rating of “Moderate Buy” by Analysts

Heartflow, Inc. (NASDAQ: HTFL - Get Free Report) has received a consensus rating of "Moderate Buy" f

Heartflow Files Patent Infringement Lawsuit Against Cleerly
globenewswire.com
Heartflow Files Patent Infringement Lawsuit Against Cleerly

Heartflow asserts that Cleerly infringed foundational patented technology central to the Heartflow P

Campbell Rogers Sells 64,533 Shares of Heartflow (NASDAQ:HTFL) Stock
defenseworld.net
Campbell Rogers Sells 64,533 Shares of Heartflow (NASDAQ:HTFL) Stock

Heartflow, Inc. (NASDAQ: HTFL - Get Free Report) insider Campbell Rogers sold 64,533 shares of the f

How Decentralized AI is Unlocking Value in Cardiac Diagnostics
prnewswire.com
How Decentralized AI is Unlocking Value in Cardiac Diagnostics

/PRNewswire/ -- USANewsGroup.com News Commentary - Heart disease is a quiet crisis that is draining

What Investors Should Know About One HeartFlow Insider's $2 Million Stock Sale
fool.com
What Investors Should Know About One HeartFlow Insider's $2 Million Stock Sale

HeartFlow's chief medical officer exercised 67,017 options and sold 64,533 Common Stock shares on Ma

Is HeartFlow Stock a Buy After Capricorn Investment Group Bought 1.7 Million Shares?
fool.com
Is HeartFlow Stock a Buy After Capricorn Investment Group Bought 1.7 Million Shares?

HeartFlow delivers AI-powered, non-invasive cardiac diagnostics to healthcare providers seeking adva

Earnings Scheduled For March 18, 2026
benzinga.com
Earnings Scheduled For March 18, 2026

Earnings Scheduled For November 12, 2025
benzinga.com
Earnings Scheduled For November 12, 2025